Citius Pharmaceuticals, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Citius Pharmaceuticals, Inc. filing details adjustments in beneficial ownership by CVI Investments, Inc. and Heights Capital Management, Inc., primarily related to warrant exercisability.
NASDAQ
CVI Investments, Inc. and Heights Capital Management, Inc. have disclosed a combined beneficial ownership of 9.9% in Citius Pharmaceuticals, Inc. common stock.
NASDAQ
CVI Investments, Inc. and its investment manager, Heights Capital Management, Inc., have disclosed a 9.9% beneficial ownership stake in Citius Pharmaceuticals, Inc.